| Literature DB >> 34046114 |
Semra Ozdemir1, Ahmet Barutcu2, Ercan Aksit2, Ali Duygu2, Fulya Koc Ozturk1.
Abstract
BACKGROUND: Previous studies showed conflicting results about the contribution of coronary collateral circulation (CCC) to myocardial perfusion and function. The aim of this study was to investigate these contradictory problems by gated myocardial perfusion scintigraphy (gated MPS) for the first time.Entities:
Keywords: Coronary collateral circulation; Gated; Myocardial function; Myocardial perfusion scintigraphy; Phase analysis
Year: 2021 PMID: 34046114 PMCID: PMC8139745 DOI: 10.14740/cr1262
Source DB: PubMed Journal: Cardiol Res ISSN: 1923-2829
Demographic and Clinical Parameters of Groups
| Clinical characteristics | Patients cohort (n = 96) | P value | |
|---|---|---|---|
| Not-well-developed collateral group (n = 58) | Well-developed collateral group (n = 38) | ||
| The mean age (years) | 64.05 ± 10.13 | 61.71 ± 11.69 | 0.300 |
| Gender, n (%) | |||
| Male | 41 (70.7) | 28 (73.7) | 0.750 |
| Female | 17 (29.3) | 10 (26.3) | |
| Body mass index (kg/m2) | 28.14 ± 4.31 | 29.34 ± 4.76 | 0.211 |
| Comorbidities | |||
| Diabetes mellitus, n (%) | 29 (50.0) | 11 (28.9) | 0.041* |
| Hypertension, n (%) | 23 (39.7) | 15 (39.5) | 0.986 |
| Hyperlipidemia, n (%) | 33 (57.9) | 20 (52.6) | 0.613 |
| Smoking, n (%) | 28 (48.3) | 19 (50.0) | 0.869 |
| Family history of CAD, n (%) | 32 (55.2) | 24 (63.2) | 0.438 |
| Cardiac drugs | |||
| Antihypertensive | 23 (39.7) | 15 (39.5) | 0.986 |
| Beta blocker | 50 (86.2) | 31 (81.5) | 0.516 |
| Vasodilators | 18 (31.0) | 11 (28.9) | 0.828 |
| Coronary angiography | |||
| Rentrop 0 (n) | 52 | - | |
| Rentrop 1 (n) | 6 | - | |
| Rentrop 2 (n) | - | 24 | |
| Rentrop 3 (n) | - | 14 | |
*P < 0.05. CAD: coronary artery disease.
The Statistics of Myocardial Perfusion Scintigraphy Findings in the Current Patients
| Myocardial perfusion gated SPECT imaging parameters | Patients cohort (n = 96) | P value | |
|---|---|---|---|
| Not-well-developed collateral group (n = 58) | Well-developed collateral group (n = 38) | ||
| QPS and QGS | |||
| SSS = perfusion damage score | 14.16 ± 6.41 | 15.03 ± 6.96 | 0.531 |
| SDS = ischemia score | 7.29 ± 3.26 | 7.63 ± 3.59 | 0.634 |
| SMS = motion damage score | 11.78 ± 6.47 | 11.84 ± 7.89 | 0.964 |
| Stress EF (%) | 53.21 ± 5.63 | 54.05 ± 6.31 | 0.495 |
| Left ventricular mass (g) | 128.32 ± 17.65 | 137.18 ± 14.36 | 0.011* |
| Left ventricular mass index (g/m2) | 68.96 ± 10.29 | 73.08 ± 10.40 | 0.059 |
| TID | 1.11 ± 0.17 | 1.06 ± 0.13 | 0.158 |
| Phase analysis (desynchronization scores) | |||
| PP | 147.05 ± 24.19 | 138.55 ± 20.00 | 0.075 |
| PSD | 35.07 ± 16.57 | 28.53 ± 15.08 | 0.053 |
| PHB | 69.82 ± 34.22 | 57.56 ± 29.55 | 0.074 |
*P < 0.05. SPECT: single-photon emission computerized tomography; QPS: Quantitative Perfusion SPECT; QGS: Quantitative Gated SPECT; SSS: summed stress score; SDS: summed difference score; SMS: summed motion score; EF: ejection fraction; TID: transient ischemic dilation; PP: peak phase; PSD: phase standard deviation; PHB: phase histogram bandwidth.
The Statistics of Myocardial Perfusion Scintigraphy Findings in the Current Patient’s Subgroups Divided by Coronary Arteries
| Gated myocardial perfusion scintigraphy parameters | Coronary artery subgroups (patients n = 96, coronary artery n = 116a) | P value | |||||
|---|---|---|---|---|---|---|---|
| Group1 (not-well-developed collateral group) | Group 2 (well-developed collateral group) | ||||||
| Subgroup LAD1 (n = 30) | Subgroup CX1 (n = 20) | Subgroup RCA1 (n = 26) | Subgroup LAD2 (n = 15) | Subgroup CX1 (n = 10) | Subgroup RCA2 (n = 15) | ||
| QPS and QGS | |||||||
| SSS = perfusion damage score | 8.33 ± 4.70 | 9.43 ± 3.38 | 9.65 ± 3.95 | 8.00 ± 2.92 | 8.89 ± 2.57 | 9.13 ± 4.47 | Subgroup LAD 0.809 |
| Subgroup CX 0.553 | |||||||
| Subgroup RCA 0.873 | |||||||
| SDS = ischemia score | 3.11 ± 1.51 | 3.54 ± 1.15 | 3.79 ± 1.35 | 2.98 ± 1.02 | 3.02 ± 1.03 | 3.98 ± 1.26 | Subgroup LAD 0.815 |
| Subgroup CX 0.455 | |||||||
| Subgroup RCA 0.756 | |||||||
| SMS = motion damage score | 6.67 ± 4.10 | 7.95 ± 3.58 | 8.58 ± 2.94 | 5.00 ± 2.56 | 6.33 ± 4.09 | 5.93 ± 3.15 | Subgroup LAD 0.083 |
| Subgroup CX 0.097 | |||||||
| Subgroup RCA 0.102 | |||||||
| Stress EF (%) | 52.77 ± 6.36 | 51.40 ± 6.28 | 52.38 ± 5.79 | 54.47 ± 5.52 | 54.10 ± 7.15 | 54.67 ± 5.80 | Subgroup LAD 0.537 |
| Subgroup CX 0.231 | |||||||
| Subgroup RCA 0.314 | |||||||
| Left ventricular mass (g) | 133.40 ± 21.95 | 133.60 ± 14.68 | 129.11 ± 16.29 | 137.20 ± 11,57 | 136.30 ± 15.64 | 134.73 ± 14.87 | Subgroup LAD 0.462 |
| Subgroup CX 0.475 | |||||||
| Subgroup RCA 0.253 | |||||||
| Left ventricular mass index (g/m2) | 70.76 ± 10.62 | 69.46 ± 10.41 | 70.08 ± 12.26 | 72.46 ± 11.03 | 73.45 ± 9.34 | 69.83 ± 8.45 | Subgroup LAD 0.485 |
| Subgroup CX 0.328 | |||||||
| Subgroup RCA 0.640 | |||||||
| TID | 1.12 ± 0.15 | 1.11 ± 0.18 | 1.13 ± 0.18 | 1.05 ± 0.10 | 1.04 ± 0.09 | 1.05 ± 0.13 | Subgroup LAD 0.126 |
| Subgroup CX 0.230 | |||||||
| Subgroup RCA 0.184 | |||||||
| Phase analysis (desynchronization) | |||||||
| PP | 151.03 ± 28.10 | 144.15 ± 24.58 | 146.69 ± 21.37 | 140.60 ± 17.12 | 135.70 ± 24.16 | 137.73 ± 14.73 | Subgroup LAD 0.219 |
| Subgroup CX 0.328 | |||||||
| Subgroup RCA 0.121 | |||||||
| PSD | 34.21 ± 18.94 | 36.60 ± 21.34 | 36.27 ± 16.46 | 26.80 ± 12.45 | 28.58 ± 15.98 | 30.34 ± 11.30 | Subgroup LAD 0.295 |
| Subgroup CX 0.301 | |||||||
| Subgroup RCA 0.221 | |||||||
| PHD | 70.03 ± 35.09 | 84.05 ± 44.65 | 65.53 ± 25.08 | 52.33 ± 16.14 | 66.60 ± 43.08 | 55.03 ± 20.87 | Subgroup LAD 0.135 |
| Subgroup CX 0.091 | |||||||
| Subgroup RCA 0.165 | |||||||
aSome patients had stenosis in more than one coronary artery. SSS: summed stress score; SDS: summed difference score; SMS: summed motion score; EF: ejection fraction; TID: transient ischemic dilation; PP: peak phase; PSD: phase standard deviation; PHB: phase histogram bandwidth; LAD: left artery descending; CX: circumflex artery; RCA: right coronary artery.
Figure 1An example of patient. (a) Proximal right RCA with 100% total stenosis (blue arrow) and Rentrop 3 collateral flow to the RCA from LAD (red arrow). (b) Myocardial perfusion bull’s eye image of the same patient shows infarction and minimal ischemia on the inferior wall (yellow arrows). LAD: left artery descending; RCA: right coronary artery.